Immune Therapeutics competitors

Immune Therapeutics's competitors include ANI Pharmaceuticals, Catalyst Pharmaceuticals, Alnylam Pharmaceuticals and Aerie Pharmaceuticals
Add company...
Immune Therapeutics
Immune Therapeutics is a specialty pharmaceutical company involved in the manufacturing and distribution of immunotherapies.
ANI Pharmaceuticals
ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A.
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases.
Alnylam Pharmaceuticals
Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
Aerie Pharmaceuticals
Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.
Founding Date
Founding Date
2012
Founding Date
1996
Founding Date
2002
Founding Date
2002
Founding Date
2005
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Orlando, US HQ
Locations
Baudette, US HQ
Baudette, US
Locations
Coral Gables, US HQ
Locations
Cambridge, US HQ
Zug, CH
Windsor And Maidenhead, GB
Locations
Irvine, US HQ
Dublin, IE
Bedminster Township, US
Durham, US
Employees
Employees
10
Employees
143
Employees
18
Employees
514
Employees
9536% increase
Valuation ($)
Valuation ($)
8.4 m
Valuation ($)
803.2 m
Valuation ($)
347.8 m
Valuation ($)
10.5 b
Valuation ($)
2.8 b
Twitter followers
Twitter followers
94
Twitter followers
N/A
Twitter followers
436
Twitter followers
8 k
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
$3.5k (FY, 2016)
Revenue (est.)
$176.8m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
($19.8m) (FY, 2016)
Net income
N/A
Net income
($18.4m) (FY, 2017)
Net income
($490.9m) (FY, 2017)
Net income
($145.1m) (FY, 2017)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 710m
Total funding raised
$ 388.6m
For sources of this data, please see the company profileDownload Excel

View company profiles

ANI Pharmaceuticals
HQ
Baudette, US
Employees
143

ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A.

View company
Catalyst Pharmaceuticals
HQ
Coral Gables, US
Employees
18

Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases.

View company
Alnylam Pharmaceuticals
HQ
Cambridge, US
Employees
514

Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.

View company
Aerie Pharmaceuticals
HQ
Irvine, US
Employees
95↑ 36% increase

Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.

View company